KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Idexx Laboratories (IDXX) Total Current Liabilities: 2009-2025

Historic Total Current Liabilities for Idexx Laboratories (IDXX) over the last 16 years, with Sep 2025 value amounting to $1.3 billion.

  • Idexx Laboratories' Total Current Liabilities rose 24.04% to $1.3 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $1.3 billion, marking a year-over-year increase of 24.04%. This contributed to the annual value of $1.1 billion for FY2024, which is 12.23% up from last year.
  • Per Idexx Laboratories' latest filing, its Total Current Liabilities stood at $1.3 billion for Q3 2025, which was up 2.28% from $1.2 billion recorded in Q2 2025.
  • Idexx Laboratories' 5-year Total Current Liabilities high stood at $1.3 billion for Q3 2025, and its period low was $620.7 million during Q1 2021.
  • For the 3-year period, Idexx Laboratories' Total Current Liabilities averaged around $1.1 billion, with its median value being $1.1 billion (2023).
  • Per our database at Business Quant, Idexx Laboratories' Total Current Liabilities dropped by 26.66% in 2021 and then skyrocketed by 87.73% in 2022.
  • Idexx Laboratories' Total Current Liabilities (Quarterly) stood at $763.6 million in 2021, then soared by 61.84% to $1.2 billion in 2022, then declined by 23.00% to $951.5 million in 2023, then increased by 12.23% to $1.1 billion in 2024, then rose by 24.04% to $1.3 billion in 2025.
  • Its Total Current Liabilities stands at $1.3 billion for Q3 2025, versus $1.2 billion for Q2 2025 and $1.1 billion for Q1 2025.